Automated Insulin Delivery Ups Time in Target Glucose Range in T1D
Percentage of time in target glucose range increased with open-source AID versus sensor-augmented insulin pump.
Stay updated with breaking news from Mercedesj Burnside. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Percentage of time in target glucose range increased with open-source AID versus sensor-augmented insulin pump.
FRIDAY, Sept. 9, 2022 (HealthDay News) -- Among patients with type 1 diabetes, percentage of time in the target glucose range is increased with the use of an open-source automated insulin delivery (AID) system, according to a study published in the Sept. 8 issue of the New England Journal of Medicine. Mercedes J. Burnside, M.B.,
Results from the CREATE trial demonstrated efficacy and safety, and 'further support the feasibility of implementing an open-source system,' an editorialist writes.